SENSEX NIFTY

Breast Cancer Drug

Mar 28, 2017 at 09:29 | Source: Moneycontrol.com
The company has received United States Food and Drug Administration (USFDA) approval for cancer drug Zejula Capsules, for Tesaro Inc.
Mar 27, 2017 at 13:05 | Source: Reuters
Tagrisso is designed to help cancer patients with certain genetic mutations that are very common in China and the regulatory green light boosts the British drugmaker's prospects in a key therapy area.
Mar 24, 2017 at 16:33 | Source: PTI
A safe and effective drug to reverse ageing and treat cancer may be available in just three years, thanks to scientists who have identified a critical step in how cells repair damaged DNA.
Mar 03, 2017 at 13:59 | Source: Moneycontrol.com
The court allowed the firm to make and sell Canmab, a cancer drug of the company. Stock was under pressure so far on the back of inspection reports. The management, earlier this morning, stated the inspections were expected as its dossiers were accepted by US FDA and EMA.
Mar 02, 2017 at 19:00 | Source: PTI
"Once the designated authority has given approval, you cannot say prima facie you have case over that. Till that (approval) is disturbed by an order of the court, it will remain," a bench of justices Badar Durrez Ahmed and Sanjeev Sachdeva said.
Feb 28, 2017 at 14:36 | Source: CNBC-TV18
"Our priority is to fix the prices of drugs as soon as possible. We do get complaints and representations on the excessively high prices of other drugs", Bhupendra Singh, Chairman of NPPA told CNBC-TV18.
Feb 28, 2017 at 11:24 | Source: PTI
The approved product is indicated for cleansing of the colon in preparation of colonoscopy in adults. Suprep Bowel Prep Kit had US sales of USD 207.2 million.
Feb 22, 2017 at 20:38 | Source: PTI
The Delhi High Court today told Swiss pharma major Roche that it "cannot hang on to" breast cancer drug Trastuzumab, innovated by it, for the rest of its life after having enjoyed the fruits of its patent.
Feb 17, 2017 at 09:51 | Source: CNBC-TV18
Biocon Thursday announced the US Food and Drug Administration has accepted Mylans Biologics License Application (BLA) for biosimilar chemotherapy drug Pegfilgrastim for review. Sharing details on the development with CNBC-TV18 Biocon Chairperson and Managing Director Kiran Mazumdar Shaw said, "This is a very important acceptance."
Feb 08, 2017 at 18:00 | Source: Moneycontrol.com
The drug makers much anticipated launch of key blood cancer treatment drug imatinib mesylate in US is facing the risk of further delay, as a partner which the company contracted to supply the drug has hit regulatory compliance hurdle.
Messages on Breast Cancer Drug »

pennystktra
der

New Member

2 Followers

Biocon  

The legal battle involving drugmaker Roche s breast cancer drug Trastuzumab took a significant turn on Friday with the Delhi High Court allowing drugmakers Biocon and Mylan to sell their version of the biosimilar drug for three treatment indications.

2.03 PM Mar 6th

Wire News

Platinum Member

725 Followers

News Now  

The Delhi High Court today told Swiss pharma major Roche that it "cannot hang on to" breast cancer drug Trastuzumab, innovated by it, for the rest of its life after having enjoyed the fruits of its patent.

8.38 PM Feb 22nd

Khushi1979

New Member

1 Followers

GAIL  

Source:----BS:----) Strong growth prospects: In Biocon, investors see a blockbuster pipeline US nod to application for breast cancer drug is latest positive for the stock Ujjval Jauhari | New Delhi January 18, 2017 Last Updated at 10:53 IST

10.55 AM Jan 19th

k.v.renga

Platinum Member

1479 Followers

Biocon  

Source:----BS:----) Strong growth prospects: In Biocon, investors see a blockbuster pipeline US nod to application for breast cancer drug is latest positive for the stock Ujjval Jauhari | New Delhi January 18, 2017 Last Updated at 10:53 IST

9.48 PM Jan 18th

Web Messenger

Platinum Member

369134 Followers

News Now  

Source:Wall Street Journal - By Marta Falconi ZURICH (Dow Jones)--Positive fresh data on Roche Holding AG's (ROG.VX) newest breast cancer drug is expected to be displayed in the US next month at a high-profile medical meeting. Roche is planning to present additional data from key

4.43 PM May 22nd 2012

biomagic

New Member

19 Followers

Biocon  

Excellent news here- DGCI approvals come handy, the company can start selling the breast cancer drug with immediate effect in India & 3rd world. impact of this will be bumper results in 4th quarter.

11.23 PM Mar 5th

biomagic

New Member

19 Followers

Biocon  

DGCI approves breast cancer drug, stock to fly high

5.40 PM Mar 5th

koppik

Gold Member

11 Followers

Biocon  

Roche case against Biocon and Mylan - next hearing on March 2nd. But judge tells Roche they can`t claim furits of patent for lifetime! http://www.ptinews.com/news/8435063_You-cannot-hang-on-to-breast-cancer-drug--HC-to-Roche-.html

3.34 AM Feb 26th

Web Messenger

Platinum Member

369134 Followers

News Now  

Source:Bloomberg - An experimental breast cancer drug from Roche Holding AG (ROG) that carries chemotherapy directly into malignant cells while bypassing healthy ones delayed tumors longer and with fewer side effects than an established therapy.

12.31 AM Jun 8th 2012

Web Messenger

Platinum Member

369134 Followers

News Now  

Source:Forbes - An experimental breast cancer drug being developed by tiny Celldex Therapeutics of Needham., Mass., appeared to show a potent tumor-shrinking effect in four women who had both an especially hard-to-treat form of breast cancer and whose tumors had high levels of the protein targeted

7.25 PM May 27th 2012

News across the web »
Apr 15, 2014 at 14:00 | Source: Bloomberg
Follow us on
Available On